Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4

Neurodegenerative upper motor neuron (UMN) syndromes ranging from primary lateral sclerosis (PLS) to pure and complicated types of hereditary spastic paraplegia (HSP) remain challenging to differentiate clinically, especially in the early stages of disease. As they share the hallmark of spastic para...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kessler, Christoph (VerfasserIn) , Wilke, Carlo (VerfasserIn) , Hengel, Holger (VerfasserIn) , Rattay, Tim W. (VerfasserIn) , Maleska Maceski, Aleksandra (VerfasserIn) , Kuhle, Jens (VerfasserIn) , Schöls, Ludger (VerfasserIn) , Schüle-Freyer, Rebecca (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 September 2025
In: Amyotrophic lateral sclerosis & frontotemporal degeneration
Year: 2025, Pages: 1-8
ISSN:2167-9223
DOI:10.1080/21678421.2025.2557936
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/21678421.2025.2557936
Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/full/10.1080/21678421.2025.2557936
Volltext
Verfasserangaben:Christoph Kessler, Carlo Wilke, Holger Hengel, Tim W. Rattay, Aleksandra Maleska Maceski, Jens Kuhle, Ludger Schöls, und Rebecca Schüle

MARC

LEADER 00000caa a22000002c 4500
001 1951157737
003 DE-627
005 20260205110317.0
007 cr uuu---uuuuu
008 260204s2025 xx |||||o 00| ||eng c
024 7 |a 10.1080/21678421.2025.2557936  |2 doi 
035 |a (DE-627)1951157737 
035 |a (DE-599)KXP1951157737 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kessler, Christoph  |e VerfasserIn  |0 (DE-588)1193061342  |0 (DE-627)167159519X  |4 aut 
245 1 0 |a Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4  |c Christoph Kessler, Carlo Wilke, Holger Hengel, Tim W. Rattay, Aleksandra Maleska Maceski, Jens Kuhle, Ludger Schöls, und Rebecca Schüle 
264 1 |c 17 September 2025 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.02.2026 
520 |a Neurodegenerative upper motor neuron (UMN) syndromes ranging from primary lateral sclerosis (PLS) to pure and complicated types of hereditary spastic paraplegia (HSP) remain challenging to differentiate clinically, especially in the early stages of disease. As they share the hallmark of spastic paraparesis, easily accessible biomarkers are warranted to facilitate an early diagnosis. We examined serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) as diagnostic biomarkers to differentiate PLS from HSP, represented by two paradigmatic subtypes: SPG4, the most common type of pure HSP, and adrenomyeloneuropathy (AMN), a common complicated form of HSP. In addition to sNfL and sGFAP raw levels, we used age-adjusted z-scores to account for age-related biomarker level increases. In our cohort of 18 PLS patients, 18 AMN patients, 25 SPG4 patients and 60 controls, sNfL z-scores were higher in PLS than in SPG4 (p < 0.001), AMN (p = 0.03), and controls (p < 0.001). Furthermore, sNfL z-scores allowed distinguishing PLS from SPG4 (AUC 0.82, 95% CI 0.67-0.98) and—slightly less accurate—from AMN (AUC 0.77, 95% CI 0.60-0.95). sGFAP z-scores did not differ significantly between groups. Our study suggests that serum NfL, but not GFAP, is a potential diagnostic biomarker in degenerative UMN diseases and may help to differentiate PLS from pure and complicated forms of HSP. Our results indicate that axonal degeneration—the source of NfL release—is predominant over astrocytic pathology—the source of GFAP release—in PLS, AMN, and SPG4. 
650 4 |a Biomarker 
650 4 |a GFAP 
650 4 |a HSP 
650 4 |a NfL 
650 4 |a PLS 
700 1 |a Wilke, Carlo  |e VerfasserIn  |4 aut 
700 1 |a Hengel, Holger  |e VerfasserIn  |4 aut 
700 1 |a Rattay, Tim W.  |e VerfasserIn  |4 aut 
700 1 |a Maleska Maceski, Aleksandra  |e VerfasserIn  |4 aut 
700 1 |a Kuhle, Jens  |e VerfasserIn  |4 aut 
700 1 |a Schöls, Ludger  |e VerfasserIn  |4 aut 
700 1 |a Schüle-Freyer, Rebecca  |d 1975-  |e VerfasserIn  |0 (DE-588)137544472  |0 (DE-627)695848283  |0 (DE-576)30411118X  |4 aut 
773 0 8 |i Enthalten in  |t Amyotrophic lateral sclerosis & frontotemporal degeneration  |d Abingdon : Taylor Francis Group, 2013  |g (2025), Seite 1-8  |h Online-Ressource  |w (DE-627)737292997  |w (DE-600)2705061-0  |w (DE-576)379474158  |x 2167-9223  |7 nnas  |a Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4 
773 1 8 |g year:2025  |g pages:1-8  |g extent:8  |a Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4 
856 4 0 |u https://doi.org/10.1080/21678421.2025.2557936  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u https://www.tandfonline.com/doi/full/10.1080/21678421.2025.2557936  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20260204 
993 |a Article 
994 |a 2025 
998 |g 137544472  |a Schüle-Freyer, Rebecca  |m 137544472:Schüle-Freyer, Rebecca  |d 910000  |d 911100  |e 910000PS137544472  |e 911100PS137544472  |k 0/910000/  |k 1/910000/911100/  |p 8  |y j 
999 |a KXP-PPN1951157737  |e 4876531935 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 04.02.2026"],"person":[{"family":"Kessler","role":"aut","given":"Christoph","display":"Kessler, Christoph"},{"given":"Carlo","display":"Wilke, Carlo","family":"Wilke","role":"aut"},{"family":"Hengel","role":"aut","given":"Holger","display":"Hengel, Holger"},{"display":"Rattay, Tim W.","given":"Tim W.","family":"Rattay","role":"aut"},{"family":"Maleska Maceski","role":"aut","display":"Maleska Maceski, Aleksandra","given":"Aleksandra"},{"family":"Kuhle","role":"aut","display":"Kuhle, Jens","given":"Jens"},{"given":"Ludger","display":"Schöls, Ludger","family":"Schöls","role":"aut"},{"given":"Rebecca","display":"Schüle-Freyer, Rebecca","role":"aut","family":"Schüle-Freyer"}],"recId":"1951157737","language":["eng"],"name":{"displayForm":["Christoph Kessler, Carlo Wilke, Holger Hengel, Tim W. Rattay, Aleksandra Maleska Maceski, Jens Kuhle, Ludger Schöls, und Rebecca Schüle"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"17 September 2025"}],"relHost":[{"disp":"Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4Amyotrophic lateral sclerosis & frontotemporal degeneration","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"ALS"},{"title":"Amyotrophic lateral sclerosis and frontotemporal degeneration"}],"language":["eng"],"part":{"extent":"8","pages":"1-8","text":"(2025), Seite 1-8","year":"2025"},"pubHistory":["14.2013 -"],"note":["Gesehen am 20.11.18"],"title":[{"title_sort":"Amyotrophic lateral sclerosis & frontotemporal degeneration","subtitle":"ALS ; official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases","title":"Amyotrophic lateral sclerosis & frontotemporal degeneration"}],"id":{"zdb":["2705061-0"],"issn":["2167-9223"],"eki":["737292997"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Abingdon ; London","dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisher":"Taylor Francis Group ; Informa Healthcare"}],"recId":"737292997"}],"physDesc":[{"extent":"8 S."}],"id":{"eki":["1951157737"],"doi":["10.1080/21678421.2025.2557936"]},"title":[{"title":"Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4","title_sort":"Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a KESSLERCHRSERUMNFLBU1720